Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB104 Phase 2 trial in Japan
jRCT2080224944Phase 2Completed
- Sponsor
- Biogen
- Start
- Nov 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of pesampator in mental disorder (3 arms), sponsored by Biogen. Primary endpoint: Change from baseline in MCCB Working Memory Domain at Week 12. Started Nov 2019; status: completed.
02
Drugs
pesampator
03
Conditions
mental disorder
Beyond the preview
Go deeper on jRCT2080224944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224944.